• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Arcus Biosciences, Inc. Common Stock (NY:RCUS)

20.94 -0.41 (-1.92%)
Streaming Delayed Price Updated: 11:24 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Arcus Biosciences, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
January 07, 2026
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 18, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
December 12, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
December 09, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
November 18, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
October 30, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
October 30, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update
October 28, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Taiho Pharmaceutical Exercises Option for an Exclusive License to Casdatifan in Japan and Certain Territories in Asia
October 19, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed 26.7 Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase 2 EDGE-Gastric Study
October 12, 2025
From Arcus Biosciences, Inc.
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
October 09, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Presents New Data for its HIF-2a Inhibitor Casdatifan and Discloses First Inflammation Programs at Investor Event
October 06, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
September 24, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
September 08, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation
September 02, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
August 20, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Reports Second-Quarter 2025 Financial Results and Provides a Pipeline Update
August 06, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
July 24, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences’ Quemliclustat Receives Orphan Drug Designation for Pancreatic Cancer
July 10, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
June 24, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
June 10, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
June 01, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
May 27, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
May 09, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Reports First-Quarter 2025 Financial Results and Provides a Pipeline Update
May 06, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
April 24, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Present First Combination Data for HIF-2a Inhibitor Casdatifan Plus Cabozantinib in an Oral Presentation at the 2025 ASCO Annual Meeting
April 23, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2025 Financial Results and Pipeline Update
April 22, 2025
From Arcus Biosciences
Via Business Wire
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
April 09, 2025
From Arcus Biosciences
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap